
    
      Pretreated, unresectable locally advanced or metastatic Human Epidermal Growth Factor
      Receptor 2 (HER2)-positive or HER2-low expressing breast cancer (BC) with untreated or
      treated brain metastases (BMs) or leptomeningeal carcinomatosis (LMC).
    
  